Axcella Health, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Employees
- 101
- Market Cap
- -
- Website
- http://www.axcellahealth.com
Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection
- Conditions
- Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2022-10-20
- Lead Sponsor
- Axcella Health, Inc
- Target Recruit Count
- 41
- Registration Number
- NCT05152849
- Locations
- ๐ฌ๐ง
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
- First Posted Date
- 2021-05-10
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Axcella Health, Inc
- Target Recruit Count
- 273
- Registration Number
- NCT04880187
- Locations
- ๐บ๐ธ
National Research Institute, Los Angeles, California, United States
๐บ๐ธSynergy Healthcare, Bradenton, Florida, United States
๐บ๐ธTampa Bay Medical Research , Inc., Clearwater, Florida, United States
Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy
- First Posted Date
- 2021-03-25
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Axcella Health, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT04816916
- Locations
- ๐บ๐ธ
University of Iowa, Iowa City, Iowa, United States
๐บ๐ธUniversity of Virginia School of Medicine, Charlottesville, Virginia, United States
๐บ๐ธMcGuire Research Institute, Inc., McGuire VA Medical Center, Richmond, Virginia, United States
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
- Conditions
- Hepatic Insufficiency
- Interventions
- Dietary Supplement: AXA1665Dietary Supplement: Placebo
- First Posted Date
- 2019-11-01
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Axcella Health, Inc
- Target Recruit Count
- 60
- Registration Number
- NCT04147936
- Locations
- ๐บ๐ธ
UPMC Center for Liver Disease, Pittsburgh, Pennsylvania, United States
๐บ๐ธDelta Research Partners, Bastrop, Louisiana, United States
๐บ๐ธVirginia Commonwealth University, Richmond, Virginia, United States
To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease
- Conditions
- To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell DiseaseSickle Cell DisordersSickle Cell DiseaseAnemia, Sickle CellSickle Cell Anemia
- Interventions
- Dietary Supplement: AXA4010
- First Posted Date
- 2019-10-22
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Axcella Health, Inc
- Target Recruit Count
- 9
- Registration Number
- NCT04134299
- Locations
- ๐บ๐ธ
Foundation for Sickle Cell Disease Research, Hollywood, Florida, United States
๐บ๐ธAdvanced Pharma CR, LLC, Miami, Florida, United States
๐บ๐ธPrimary Care research, Atlanta, Georgia, United States
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
- Conditions
- NAFLD
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: AXA1957Dietary Supplement: AXA1125
- First Posted Date
- 2019-08-29
- Last Posted Date
- 2021-07-06
- Lead Sponsor
- Axcella Health, Inc
- Target Recruit Count
- 112
- Registration Number
- NCT04073368
- Locations
- ๐บ๐ธ
Pinnacle Clinical Research, San Antonio, Texas, United States
๐บ๐ธNational Research Institute - Wilshire, Los Angeles, California, United States
๐บ๐ธNational Research Institute, Huntington Park, California, United States
Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
- Conditions
- NAFLD
- Interventions
- Dietary Supplement: AXA1957Dietary Supplement: Placebo
- First Posted Date
- 2019-08-29
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Axcella Health, Inc
- Target Recruit Count
- 9
- Registration Number
- NCT04073407
- Locations
- ๐ฌ๐ง
Royal London Children's Hospital, London, United Kingdom
๐ฌ๐งKing's College Hospital, London, United Kingdom
๐ฌ๐งRoyal Manchester Children's Hospital, Manchester, United Kingdom